Constantin Efthymiopoulos

804 total citations
16 papers, 636 citations indexed

About

Constantin Efthymiopoulos is a scholar working on Pharmacology, Epidemiology and Oncology. According to data from OpenAlex, Constantin Efthymiopoulos has authored 16 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in Constantin Efthymiopoulos's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Pneumonia and Respiratory Infections (5 papers) and Analytical Methods in Pharmaceuticals (3 papers). Constantin Efthymiopoulos is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Pneumonia and Respiratory Infections (5 papers) and Analytical Methods in Pharmaceuticals (3 papers). Constantin Efthymiopoulos collaborates with scholars based in United Kingdom, United States and Italy. Constantin Efthymiopoulos's co-authors include Alan Bye, Lindsey Cass, Allan N. Maroli, Steven L. Bramer, Christos Reppas, Eric Galia, Eleftheria Nicolaides, Jennifer Dressman, M. Strolin Benedetti and Giuseppe M. Peretti and has published in prestigious journals such as European Journal of Pharmacology, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Constantin Efthymiopoulos

16 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Constantin Efthymiopoulos United Kingdom 12 215 138 130 96 88 16 636
Konrad E. Tomaszewski United States 11 216 1.0× 58 0.4× 108 0.8× 225 2.3× 92 1.0× 18 753
Araz Raoof Belgium 11 85 0.4× 99 0.7× 48 0.4× 142 1.5× 77 0.9× 22 608
I Bekersky United States 17 127 0.6× 37 0.3× 123 0.9× 185 1.9× 149 1.7× 37 814
Ricardo Nalda‐Molina Spain 11 38 0.2× 88 0.6× 105 0.8× 102 1.1× 126 1.4× 25 437
Yun‐Kyoung Song South Korea 18 91 0.4× 312 2.3× 68 0.5× 353 3.7× 81 0.9× 62 1.0k
H Vergin Switzerland 11 79 0.4× 44 0.3× 177 1.4× 81 0.8× 53 0.6× 56 544
Bojan Stanimirov Serbia 13 79 0.4× 124 0.9× 55 0.4× 218 2.3× 188 2.1× 31 597
Carol Gleason United States 16 128 0.6× 48 0.3× 372 2.9× 242 2.5× 155 1.8× 43 920
Casey L. Sayre Canada 13 35 0.2× 63 0.5× 82 0.6× 190 2.0× 74 0.8× 27 590
HJ Rogers United Kingdom 21 55 0.3× 36 0.3× 197 1.5× 262 2.7× 153 1.7× 38 948

Countries citing papers authored by Constantin Efthymiopoulos

Since Specialization
Citations

This map shows the geographic impact of Constantin Efthymiopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constantin Efthymiopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constantin Efthymiopoulos more than expected).

Fields of papers citing papers by Constantin Efthymiopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constantin Efthymiopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constantin Efthymiopoulos. The network helps show where Constantin Efthymiopoulos may publish in the future.

Co-authorship network of co-authors of Constantin Efthymiopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Constantin Efthymiopoulos. A scholar is included among the top collaborators of Constantin Efthymiopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constantin Efthymiopoulos. Constantin Efthymiopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Perdetzoglou, Dimitrios, Constantin Efthymiopoulos, & Catherine Harvala. (2000). A chemometric comparison of three taxa of Scabiosa L.s.l.. Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology. 134(1). 67–70. 9 indexed citations
2.
Nicolaides, Eleftheria, Eric Galia, Constantin Efthymiopoulos, Jennifer Dressman, & Christos Reppas. (1999). Forecasting the In Vivo Performance of Four Low Solubility Drugs from Their In Vitro Dissolution Data. Pharmaceutical Research. 16(12). 1876–1882. 136 indexed citations
3.
Cass, Lindsey, Constantin Efthymiopoulos, & Alan Bye. (1999). Pharmacokinetics of Zanamivir After Intravenous, Oral, Inhaled or Intranasal Administration to Healthy Volunteers. Clinical Pharmacokinetics. 36(Supplement 1). 1–11. 162 indexed citations
4.
Cass, Lindsey, Constantin Efthymiopoulos, Julie Marsh, & Alan Bye. (1999). Effect of Renal Impairment on the Pharmacokinetics of Intravenous Zanamivir. Clinical Pharmacokinetics. 36(Supplement 1). 13–19. 21 indexed citations
5.
Plusquellec, Y., et al.. (1999). A pharmacokinetic model for multiple sites discontinuous gastrointestinal absorption. Medical Engineering & Physics. 21(8). 525–532. 23 indexed citations
6.
Efthymiopoulos, Constantin, et al.. (1997). Concentration of cefuroxime in middle ear effusion of children with acute otitis media. The Pediatric Infectious Disease Journal. 16(10). 959–962. 7 indexed citations
7.
Efthymiopoulos, Constantin, Steven L. Bramer, & Allan N. Maroli. (1997). Effect of Food and Gastric pH on the Bioavailability of Grepafloxacin. Clinical Pharmacokinetics. 33(Supplement 1). 18–24. 32 indexed citations
8.
Efthymiopoulos, Constantin, Steven L. Bramer, & Allan N. Maroli. (1997). Effect of Age and Gender on the Pharmacokinetics of Grepafloxacin. Clinical Pharmacokinetics. 33(Supplement 1). 9–17. 17 indexed citations
9.
Efthymiopoulos, Constantin, et al.. (1997). Effect of Renal Impairment on the Pharmacokinetics of Grepafloxacin. Clinical Pharmacokinetics. 33(Supplement 1). 32–38. 18 indexed citations
10.
Efthymiopoulos, Constantin, Steven L. Bramer, & Allan N. Maroli. (1997). Pharmacokinetics of Grepafloxacin after Oral Administration of Single and Repeat Doses in Healthy Young Males. Clinical Pharmacokinetics. 33(Supplement 1). 1–8. 54 indexed citations
11.
Efthymiopoulos, Constantin, Steven L. Bramer, Allan N. Maroli, et al.. (1997). Grepafloxacin Pharmacokinetics in Individuals with Hepatic Dysfunction. Clinical Pharmacokinetics. 33(Supplement 1). 25–31. 11 indexed citations
12.
Cosson, Valérie, Eliane Fuseau, Constantin Efthymiopoulos, & Alan Bye. (1997). Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development. I: Interspecies Allometric Scaling. Journal of Pharmacokinetics and Biopharmaceutics. 25(2). 149–167. 30 indexed citations
13.
Efthymiopoulos, Constantin, et al.. (1997). Theophylline and Warfarin Interaction Studies with Grepafloxacin. Clinical Pharmacokinetics. 33(Supplement 1). 39–46. 26 indexed citations
14.
Camaggi, Carlo Maurizio, Elena Strocchi, Andrea Martoni, et al.. (1992). Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover study. Cancer Chemotherapy and Pharmacology. 30(4). 307–316. 30 indexed citations
15.
Etienne, Marie‐Christine, G. Milano, M. Strolin Benedetti, et al.. (1991). Improved Bioavailability of a New Oral Preparation of Medroxyprogesterone Acetate. Journal of Pharmaceutical Sciences. 80(12). 1130–1132. 7 indexed citations
16.
Benedetti, M. Strolin, P. Dostert, Domenico Barone, et al.. (1990). In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine. European Journal of Pharmacology. 187(3). 399–408. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Konrad E. Tomaszewski Breakdown of academic impact, for papers by Araz Raoof Breakdown of academic impact, for papers by I Bekersky Breakdown of academic impact, for papers by Ricardo Nalda‐Molina Breakdown of academic impact, for papers by Yun‐Kyoung Song Breakdown of academic impact, for papers by H Vergin Breakdown of academic impact, for papers by Bojan Stanimirov Breakdown of academic impact, for papers by Carol Gleason Breakdown of academic impact, for papers by Casey L. Sayre Breakdown of academic impact, for papers by HJ Rogers
Rankless by CCL
2026